Aptar Pharma is introducing its new, simple and intuitive solution to comply with newly established standards regarding Child Resistance and Senior Friendliness of nasal sprays.
The technology does not interfere with the nasal spray's basic function and consequently does not impact spray performance or delivered dose. Your formulation is not exposed to any new contact materials.
KEY FEATURES:
1. Simple and intuitive solution
2. Perfect balance between Child Resistant and Senior Friendly
3. Widely established CR closure technology (squeeze and turn)
4. No impact on spray performance or delivered dose
5. Easy to handle on existing filling and packaging lines
6. Fully industrialized solution
7. Provides audible feedback
8. Compliant with 16 CFR 1700.20 (Rating F=1) and ISO 8317 (2003)
Leave a comment